Lupin to acquire two inhalation brands from Sunovion for $75 million EP News Bureau Oct 20, 2022 Brovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary…
Cipla gets USFDA nod for inhalation product EP News Bureau Jun 24, 2021 The approved product is a generic version of Sunovion Pharmaceuticals Inc's Brovana
Lupin launches generic version of Brovana in US EP News Bureau Jun 3, 2021 It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD